Lyell Immunopharma · 8 hours ago
Senior Director, Investor Relations and Corporate Communications
South San Francisco, California, United States
Full-time
Onsite
Director/Executive
$240K/yr - $280K/yr
10+ years expLyell Immunopharma is a clinical-stage company focused on advancing next-generation CAR T-cell therapies for cancer treatment. The Senior Director, Investor Relations and Corporate Communications is responsible for developing and executing a communications strategy to effectively engage with the investor community and ensure clear messaging about the company's scientific and clinical progress.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Collaborate with the C-suite and product teams to develop and execute a communications strategy to share the importance of Lyell with investors via quarterly filings, conference calls, investor conferences, and roadshows
Ensure that there is effective and consistent execution on the corporate communications strategy to ensure optimal outreach to investors and analysts to keep Lyell’s strategy and progress top of mind
Lead, develop and execute a comprehensive, strategic communications strategy and tactical plan to achieve key investor relations objectives; evolve as needed
Partner with Finance and Legal to ensure investor-facing communications are robust, timely and accurate, and provide compelling messaging and information
Develop written materials, such as key messages, FAQs and talking points to effectively communicate the company’s positioning, decision, or program updates for conference calls and other investor/analysts events
Train, advise, and develop spokespeople for media interviews, press conferences, and industry presentations; prepare talking points and briefing documents, as needed
Leverage existing network and build strong relationships with analysts, investors, members of the press, influencers, and partners, including serving as an on-record spokesperson, per the external communications strategy
Partner with media, identified PR agency, and external partners as needed to develop and execute campaigns, outreach programs, and monitor brand activity
Maintain a thorough understanding of our corporate strategy and the importance of each stakeholder segment to our corporate and scientific portfolio and messaging
Manage daily proactive and responsive communications for the company, including devising a crisis communications strategy and rapid response efforts
Keep track of the developments and public announcements by our competitors and peer companies
Qualification
Required
Bachelor's Degree in a Scientific discipline preferred; Communications, Marketing, or related field considered with significant biotech industry experience
Minimum 10 years' experience in public relations (preferably investor relations), corporate communications, or media with a strong understanding of business needs and competitive challenges in the life science industry
Minimum 8 years' experience in management and leadership roles in mid to large size organizations
Experience in the biotech industry in investor relations and corporate communications or as sell-side analyst
Effective track record in managing investor relations strategy and supporting significant initiatives such as financing, conference participation, and product launches
Proven written and verbal communication strength with the ability to tailor messages to a diverse set of audiences and define the various voices of Lyell (internal, external, etc.)
Strong, proven executive leadership experience with business/corporate development or operations familiarity
Cross-functional experience leading through complexity, with the ability to influence and collaborate with multiple stakeholders at all levels across functions and levels
Strong executive presence with the ability to lead executive discussions, focus on detail and think strategically
Collaborative leadership style
Track record of prioritizing and executing competing priorities in a fast-moving environment
Willingness to “roll-up your sleeves” managing a diverse set of objectives, shifting fluidly from strategy to execution consistent with a start-up environment
Agile and creative thinker in external communications; uses sound judgement
Preferred
Master's Degree a plus
Benefits
Subsidized medical, dental and vision plans from your first day of employment
FSA
Company provided Life and AD&D Insurance
STD and LTD Insurance
ESPP
A 401(k) Plan with Company match
Mass transit commuter benefits
Cell phone reimbursement
A range of supplemental benefits that you may choose to elect
Flex Time off
Sick leave
8 observed holidays
A floating holiday
Winter office shutdown
Company
Lyell Immunopharma
Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.
201-500 employees
H1B Sponsorship
Lyell Immunopharma has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (2)
2023 (2)
2022 (5)
2021 (2)
2020 (3)
Funding
Current Stage
Public CompanyTotal Funding
$543M2025-07-25Post Ipo Equity· $50M
2021-06-16IPO
2020-03-12Series C· $493M
Leadership Team
Lynn Seely
President & Chief Executive Officer
Gary Lee
Chief Scientific Officer
Recent News
2025-12-25
2025-12-19
2025-12-09
Company data provided by crunchbase